AstraZeneca-partnered IBS drug positive in PhII but lags Linzess
This article was originally published in Scrip
Executive Summary
Ardelyx has reported positive Phase IIb data with its AstraZeneca-partnered drug candidate tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C).